Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCatenai Plc Regulatory News (CTAI)

Share Price Information for Catenai Plc (CTAI)

Share Price is delayed by 15 minutes
Get Live Data
0.26    0.00 (0.00%)
Bid:
0.24
Ask:
0.28
Spread: 0.04 (16.667%)
Market Cap: £3.73m
CTAI Live PriceLast checked at - London Stock Exchange

Intraday Catenai Plc Share Chart

Placing, Loan Conversion, Warrants, Board Changes

12 Mar 2024 07:00

RNS Number : 4280G
Catenai PLC
12 March 2024
 

12 March 2024

 

Catenai PLC

 

("Catenai" or the "Company")

 

Placing, Conversion of Loan Facility, Issue of Warrants, Board Changes

Placing

Catenai PLC (AIM: CTAI), the AIM quoted provider of digital media and technology, announces that the Company has issued 265,533,330 new ordinary shares at a price of 0.3 pence per share ("Placing") of which 153,333,333 will be issued and allotted under existing authorities ("First Tranche"), with the balance of 112,199,997 new ordinary shares being issued and allotted conditional on approval of additional shareholder authorities, which will be sought at a General Meeting of the Company ("Second Tranche"). The General Meeting is expected to occur in early April 2024, a further announcement convening a General Meeting will be made shortly.

 

The First Tranche will be satisfied through gross proceeds of £460,000.

 

The Second Tranche will be satisfied through:-

 

Gross proceeds

£260,000

Fee shares to settle liabilities

£56,600

Accrued director fees settled in shares

£20,000

 

The gross proceeds of the Placing will be used for general working capital purposes.

 

The issue price of the Placing Shares represents a discount of 40% to the closing price per ordinary share as at the close of business on 11 March 2024.

 

Conversion of Loan Facility

Further to the announcement on 17 January 2024, the holder of the convertible loan note ("Loan Note") Sanderson Capital Limited ("Sanderson") has elected to convert £151,000 of the Loan Notes and £65,100 of Loan Note fees into new ordinary shares in the Company at a conversion price of 0.3 pence per share. Accordingly, 72,033,333 new ordinary shares will be issued to Sanderson ("Loan Note Shares").

 

Issue of Warrants

Sanderson will be issued a warrant over 25,166,666 new ordinary shares in the Company. The warrants will be exercisable for a period of 36 months from the date of Admission with an exercise price of 0.3 pence per new ordinary share ("Warrants").

 

Directors' Interests Following Placing

 

As part of the Placing, accrued director fees of £20,000 will be settled through the issue of 6,666,666 new ordinary shares at a price of 0.3 pence per share as detailed in the table below:

 

Director

Current Shares

Shares issued pursuant to the Placing (Second Tranche)

Resultant shareholding following Admission1

Resultant percentage shareholding following Admission1

John Farthing

620,837

1,666,666

2,287,503

0.58%

Brian Thompson*

6,263,759

5,000,000

11,263,759

2.85%

 

*1,666,666 new ordinary shares of Brian Thompson's new ordinary shares are being issued to Brian Thompson's spouse, in lieu of salary as a director of the Company's historical subsidiary Hyperneph Software Limited

1 Assumes admission of the Second Tranche ordinary shares is approved by shareholders at the General Meeting and admission occurs

 

Board Changes

Guy Meyer, CEO has informed the Company that he intends to step down as a director of Company, Guy has agreed to remain as a director until another director is appointed.

 

Subject to normal regulatory due diligence the Company intends to appoint Sarfraz Munshi as a Non-executive Director. A further announcement will be made in due course.

 

Brian Thompson, Chairman said "The Board thanks Guy for his service to the Company over many years and wishes him all the very best with his future endeavours. The Board is also pleased that Safraz has agreed to join the Company and looks forward to the Company's next strategic growth phase."

 

Admission and Total Voting Rights

 

Application has been made to the London Stock Exchange to admit the First Tranche shares and the Loan Note Shares, being in aggregate 225,366,666 new ordinary shares ("New Ordinary Shares") to trading on AIM. Admission of the New Ordinary Shares is expected to occur on or around 8:00 a.m. on 27 March 2024 ("Admission")

 

A further application will be made for the Second Tranche shares to be admitted to trading on AIM following the General Meeting that is expected to occur in April 2024.

 

For the purpose of the Disclosure and Transparency Rules, following the issue of the New Ordinary Shares the enlarged issued share capital of the Company will comprise 282,374,451 ordinary shares of 0.2p each. The 282,374,451 figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. The person who arranged for release of this announcement on behalf of the Company was John Farthing, Chief Financial Officer of the Company and the Directors of the Company are responsible for the release of this announcement.

 

For further information please contact:

 

Catenai PLC

+44 (0)20 7183 8666

John Farthing, Chief Financial Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

Shard Capital Partners LLP (Broker)

+44 (0)20 7186 9952

Damon Heath

 

Notes to Editors:

 

About Catenai PLC

Catenai is an AIM quoted provider of digital media and technology services. The Company specialises in IT solutions that solve commercial challenges and create opportunities for its clients, with an increasing focus incorporating AI into its platforms. The Company has an experienced IT team of project managers and integrators who have deployed systems across corporate, government and educational sectors.

 

http://www.catenaiplc.com

 

 

Caution regarding forward looking statements

 

 Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identi?ed by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements re?ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEJBMTTMTJBTMI
12
Date   Source Headline
22nd May 20267:00 amRNSKlarian Update and Webinar
14th May 20267:00 amRNS-RAlludium VC Vertical Launch & Website Update
20th Apr 20267:00 amRNSContract Renewal and Klarian Update
2nd Apr 20267:00 amRNS-RAlludium Achieves Certifications
19th Mar 20267:00 amRNSAlludium secures first paying customers
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
19th Feb 20267:00 amRNS-RUpdate re Alludium
20th Jan 20267:00 amRNS-RNew Company Website
19th Jan 202612:32 pmRNSHolding(s) in Company
5th Jan 20267:00 amRNSKlarian update
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
11th Dec 20257:00 amRNS-RInvestor Presentation
1st Dec 20257:00 amRNS-RAlludium Update
11th Nov 20257:00 amRNS-RAlludium launches new website
4th Nov 20257:00 amRNSRepayment of Loan & Issue of Warrants
30th Oct 20257:00 amRNSAlludium Commercial Launch
30th Sep 20257:00 amRNSHalf-year Report
15th Sep 20257:00 amRNS-RSVV featuring Alludium in AI Webinar series
28th Jul 20257:00 amRNSUpdate on Treasury
17th Jul 20257:00 amRNSInvestment in Alludium
15th Jul 20253:15 pmRNSResult of GM & Issue of Equity
7th Jul 20257:00 amRNSAlludium “First Look” Event
1st Jul 20257:00 amRNSNotice of GM & Further Re Fundraise
30th Jun 20257:00 amRNSFinal Results & Klarian Update
26th Jun 20257:54 amRNSFundraise of up to £1.6m
16th Jun 20257:00 amRNS-RAlludium 'First Look' Investor Event in London
9th Jun 20257:00 amRNSAlludium Strategic Program Update
27th May 20257:00 amRNSAlludium accepted into NVIDIA Inception
21st May 20257:00 amRNSFurther re investment in Alludium, Issue of Equity
15th May 20257:30 amRNSLaunch of Alludium at LangChain’s AI Conference
13th May 20257:10 amRNSInvestment in Alludium
12th May 20251:23 pmRNSResult of AGM, Issue of Equity, Warrants
6th May 202510:37 amRNSProposed Issue of Warrants
30th Apr 20253:30 pmRNSInsurance Policy Renewal
29th Apr 20251:00 pmRNSExercise of Warrant
17th Apr 20253:34 pmRNSNotice of AGM & Proposed Share Sub-division
11th Apr 20257:00 amRNSProposed Investment in Alludium, Fundraise
8th Apr 202512:30 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSKlarian update
25th Mar 20257:00 amRNSDirector Disclosure Update
17th Jan 202511:58 amRNSHolding(s) in Company
16th Jan 202510:27 amRNSHolding(s) in Company
14th Jan 202512:37 pmRNSWorking Capital Loan and Related Party Transaction
13th Jan 202510:39 amRNSKlarian CLN Update
29th Nov 20247:00 amRNSInsurance Policy Renewal & RPT
28th Oct 20247:00 amRNSKlarian update
20th Sep 20247:00 amRNSHalf-year Report
28th Jun 20247:00 amRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.